osteocyte

**Origin and structure** - Terminally differentiated osteoblasts that become trapped in the bone matrix they secrete. Their cell bodies sit in lacunae. Long, thin dendritic processes run through canaliculi. - Processes connect to neighboring osteocytes, osteoblasts, and bone-lining cells through gap junctions (connexin 43). This forms a lacunocanalicular network (a functional syncytium) that allows nutrient and signal exchange. - Osteocytes have reduced organelles compared with active osteoblasts. They are less synthetically active but remain metabolically active.

**Functions** 1. **Mechanosensation:** They detect mechanical loading through fluid shear stress in the canaliculi. This is the basis of Wolff's law (bone remodels in response to load). - Mechanical loading → ↓ sclerostin → ↑ Wnt signaling → ↑ bone formation. - Unloading (bed rest, microgravity, paralysis) → ↑ sclerostin → bone loss. 2. **Regulation of remodeling:** - They secrete **RANKL** (and OPG), which regulates osteoclast formation and activity. Osteocytes are a major RANKL source in adult remodeling. - They secrete **sclerostin (SOST gene)**, which inhibits LRP5/6 and Wnt/β-catenin signaling and therefore inhibits osteoblasts. 3. **Mineral homeostasis:** - They secrete **FGF23**, which ↓ renal phosphate reabsorption (NaPi-2a/2c) and ↓ 1α-hydroxylase activity, lowering calcitriol. - They can remodel their perilacunar matrix (osteocytic osteolysis) to release calcium, for example during lactation. - Excess FGF23 causes hypophosphatemic rickets or osteomalacia (X-linked hypophosphatemia via PHEX mutation; ADHR via FGF23 mutation; tumor-induced osteomalacia).

**Clinical correlations** - **Romosozumab:** a monoclonal antibody against sclerostin that is used for severe osteoporosis. It increases bone formation and decreases resorption. It carries a boxed warning for MI, stroke, and CV death. - **Sclerosteosis and van Buchem disease:** loss of SOST function causes high bone mass, with cranial nerve entrapment and ↑ ICP. - **Osteoporosis:** osteocyte apoptosis, driven by estrogen deficiency, glucocorticoids, and aging, impairs the detection of microdamage and leads to bone fragility. - **Osteonecrosis (avascular necrosis):** widespread osteocyte death causes empty lacunae on histology. Causes include steroids, alcohol, sickle cell disease, trauma (femoral neck fracture), and Legg-Calvé-Perthes disease. - **PTH:** continuous PTH exposure (hyperparathyroidism) ↓ sclerostin and ↑ RANKL, which increases resorption. Intermittent PTH (teriparatide) is anabolic. - **Estrogen:** it protects osteocytes from apoptosis. Loss at menopause promotes osteoporosis.

**Cell comparison (high-yield)** - **Osteoblasts:** make osteoid, express ALP, osteocalcin, and type I collagen, and are derived from mesenchymal stem cells. - **Osteocytes:** maintain the matrix and sense strain. They are the most abundant bone cell. - **Osteoclasts:** multinucleated cells derived from monocyte/macrophage lineage. They are RANK+, TRAP+, and cathepsin K+, and they resorb bone. - **Bone-lining cells:** flat, quiescent osteoblast-lineage cells on bone surfaces.

**Histology:** Osteocytes appear as small cells in lacunae within lamellar bone, arranged concentrically around the central (Haversian) canal in an osteon. Canaliculi radiate from the lacunae toward the central canal, and the osteocyte processes within them communicate with other cells.